Newton, MA, United States of America

Akira Iinishi

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Northeastern University. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Iinishi. Retrieved from https://idiyas.com/inventor/akira-iinishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akira Iinishi: Innovator in Pharmaceutical Compounds

Introduction

Akira Iinishi is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of infectious diseases. With a total of 3 patents, his work focuses on developing compounds that address critical health issues.

Latest Patents

Iinishi's latest patents include "Hygromycin A Compounds and Methods of Treating Spirochete Diseases." This invention provides compounds useful for treating spirochete diseases such as Lyme disease, along with pharmaceutical formulations and environmental baits containing these compounds. Another significant patent is for "Isolated Darobactin A Analog Compounds and Compositions Thereof." This invention relates to a novel compound for use in treating infections caused by Gram-negative bacteria.

Career Highlights

Iinishi is affiliated with Northeastern University, where he continues to advance his research and innovation in the pharmaceutical field. His work has the potential to impact the treatment of various bacterial infections significantly.

Collaborations

Iinishi collaborates with esteemed colleagues such as Kim Lewis and Yu Imai, contributing to a dynamic research environment that fosters innovation.

Conclusion

Akira Iinishi's contributions to pharmaceutical innovations highlight his commitment to addressing pressing health challenges. His patents reflect a dedication to improving treatment options for infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…